Lipella Pharmaceuticals enters asset sale deal with XRAIY in Chapter 11 case
LIPO•Asset sale approved in Chapter 11 case
Lipella Pharmaceuticals entered an asset purchase agreement with XRAIY to sell substantially all company assets.
- The U.S. Bankruptcy Court for the Western District of Pennsylvania authorized the sale under Bankruptcy Code Section 363 in an order dated June 4, 2026.
